文献速递垂体与肾上腺疾病性腺与生殖内分泌

原发性肾上腺功能不全患者血浆肾素与盐皮质激素替代剂量无关

Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究为观察性、回顾性、纵向分析,纳入204例盐丢失型先天性肾上腺皮质增生症患者(149例成人、55例儿童)及39例Addison病成人患者,共984次临床访视与血浆肾素测定。结果显示盐皮质激素剂量与血浆肾素浓度关系复杂,成人中仅血钠可预测血浆肾素,纵向剂量变化可预测血钾但不预测血压或血浆肾素。

要点

  • 盐皮质激素剂量与血浆肾素浓度的关系复杂,不宜仅凭肾素正常化调整剂量。
  • 成人中仅血钠可预测血浆肾素浓度,儿童中血压随盐皮质激素剂量增加而升高。
  • 盐皮质激素滴定应结合血压与电解质等临床指标综合判断。

核心结论

  • 盐皮质激素剂量与血浆肾素浓度的关系复杂,可能反映采样体位、末次给药时间、依从性及合并用药的差异。
  • 盐皮质激素滴定不应主要仅基于血浆肾素正常化,还应结合血压和电解质浓度等临床参数。

研究设计与样本

  • 观察性、回顾性、纵向分析,患者来自本地数据库及国际先天性肾上腺皮质增生症登记系统(www.i-cah.org)。
  • 最终分析204例盐丢失型先天性肾上腺皮质增生症患者(149例成人、55例儿童)及39例Addison病成人患者。

主要发现

  • 血浆肾素浓度低、正常、高者分别占19%、36%、44%,盐皮质激素剂量与血浆肾素浓度变异均较大。
  • 单因素分析显示成人与儿童中盐皮质激素剂量与血浆肾素浓度呈直接正相关。
  • 成人中盐皮质激素剂量与血压无关,儿童中血压随盐皮质激素剂量增加而升高。
  • 多因素回归模型中,血钠是成人中唯一可预测血浆肾素浓度的指标。
  • 纵向上,盐皮质激素剂量变化可预测血钾,但不能预测血压或血浆肾素浓度。

临床怎么用

  • 盐皮质激素剂量调整不应仅以血浆肾素正常化为目标,应同时评估血压与电解质浓度。
  • 对盐丢失型先天性肾上腺皮质增生症儿童,增加盐皮质激素剂量时需关注血压变化。

局限性

  • 为观察性、回顾性、纵向分析,可能存在采样体位、末次给药时间、依从性及合并用药等混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: No consensus exists for optimization of mineralocorticoid therapy in patients with primary adrenal insufficiency. OBJECTIVE: To explore the relationship between mineralocorticoid (MC) replacement dose, plasma renin concentration (PRC), and clinically important variables to determine which are most helpful in guiding MC dose titration in primary adrenal insufficiency. DESIGN: Observational, retrospective, longitudinal analysis. PATIENTS: A total of 280 patients (with 984 clinical visits and plasma renin measurements) with primary adrenal insufficiency were recruited from local databases and the international congenital adrenal hyperplasia (CAH) registry (www.i-cah.org). Thirty-seven patients were excluded from the final analysis due to incomplete assessment. Data from 204 patients with salt-wasting CAH (149 adults and 55 children) and 39 adult patients with Addison disease (AD) were analysed. MAIN OUTCOME MEASURES: PRC, electrolytes, blood pressure (BP), and anthropometric parameters were used to predict their utility in optimizing MC replacement dose. RESULTS: PRC was low, normal, or high in 19%, 36%, and 44% of patients, respectively, with wide variability in MC dose and PRC. Univariate analysis demonstrated a direct positive relationship between MC dose and PRC in adults and children. There was no relationship between MC dose and BP in adults, while BP increased with increasing MC dose in children. Using multiple regression modeling, sodium was the only measurement that predicted PRC in adults. Longitudinally, the change in MC dose was able to predict potassium, but not BP or PRC. CONCLUSIONS: The relationship between MC dose and PRC is complex and this may reflect variability in sampling with respect to posture, timing of last MC dose, adherence, and concomitant medications. Our data suggest that MC titration should not primarily be based only on PRC normalization, but also on clinical parameters such as BP and electrolyte concentration.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Pofi R, Prete A, Thornton-Jones V, et al. Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency. J Clin Endocrinol Metab. 2020. PMID: 31613957. doi:10.1210/clinem/dgz055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。